Generation and Characterization of Rgs4 Mutant Mice

REFERENCES

• Adams, L. D., R. L. Geary, B. McManus, and S. M. Schwartz. 2000. A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ. Res. 87:623–631.
   PubMedGoogle Scholar
• Beyer, C. E., A. Ghavami, Q. Lin, A. Sung, K. J. Rhodes, L. A. Dawson, L. E. Schechter, and K. H. Young. 2004. Regulators of G-protein signaling 4: modulation of 5-HT(1A)-mediated neurotransmitter release in vivo. Brain Res. 1022:214–220.
   PubMedGoogle Scholar
• Bishop, G. B., W. E. Cullinan, E. Curran, and H. B. Gutstein. 2002. Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol. Dis. 10:334–343.
   PubMedGoogle Scholar
• Celerier, E., M. T. Yazdi, A. Castane, S. Ghozland, F. Nyberg, and R. Maldonado. 2003. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice. Eur. J. Pharmacol. 465:69–81.
   PubMedGoogle Scholar
• Chen, X., C. Dunham, S. Kendler, X. Wang, F. A. O'Neill, D. Walsh, and K. S. Kendler. 2004. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am. J. Med. Genet. 129B:23–26.
   PubMedGoogle Scholar
• Cho, H., K. Harrison, O. Schwartz, and J. H. Kehrl. 2003. The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. Biochem. J. 371:973–980.
   PubMedGoogle Scholar
• Chowdari, K. V., K. Mirnics, P. Semwal, J. Wood, E. Lawrence, T. Bhatia, S. N. Deshpande, B. K. Thelma, R. E. Ferrell, F. A. Middleton, B. Devlin, P. Levitt, D. A. Lewis, and V. L. Nimgaonkar. 2002. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11:1373–1380.
   PubMed Web of Science ®Google Scholar
• Christie, M. J., J. T. Williams, P. B. Osborne, and C. E. Bellchambers. 1997. Where is the locus in opioid withdrawal. Trends Pharmacol. Sci. 18:134–140.
   PubMedGoogle Scholar
• Clark, M. J., C. Harrison, H. Zhong, R. R. Neubig, and J. R. Traynor. 2003. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. J. Biol. Chem. 278:9418–9425.
   PubMed Web of Science ®Google Scholar
• De Vries, L., B. Zheng, T. Fischer, E. Elenko, and M. G. Farquhar. 2000. The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40:235–271.
   PubMed Web of Science ®Google Scholar
• Doupnik, C. A., T. Xu, and J. M. Shinaman. 2001. Profile of RGS expression in single rat atrial myocytes. Biochim. Biophys. Acta 1522:97–107.
   PubMed Web of Science ®Google Scholar
• Erdely, H. A., R. A. Lahti, M. B. Lopez, C. S. Myers, R. C. Roberts, C. A. Tamminga, and M. W. Vogel. 2004. Regional expression of RGS4 mRNA in human brain. Eur. J. Neurosci. 19:3125–3128.
   PubMedGoogle Scholar
• Garnier, M., P. F. Zaratin, G. Ficalora, M. Valente, L. Fontanella, M. H. Rhee, K. J. Blumer, and M. A. Scheideler. 2003. Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine. J. Pharmacol. Exp. Ther. 304:1299–1306.
   PubMedGoogle Scholar
• Geyer, M. A., K. L. McIlwain, and R. Paylor. 2002. Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry 7:1039–1053.
   PubMed Web of Science ®Google Scholar
• Gold, S. J., M. H. Han, A. E. Herman, Y. G. Ni, C. M. Pudiak, G. K. Aghajanian, R. J. Liu, B. W. Potts, S. M. Mumby, and E. J. Nestler. 2003. Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur. J. Neurosci. 17:971–980.
   PubMedGoogle Scholar
• Gold, S. J., Y. G. Ni, H. G. Dohlman, and E. J. Nestler. 1997. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 17:8024–8037.
   PubMedGoogle Scholar
• Grillet, N., V. Dubreuil, H. D. Dufour, and J. F. Brunet. 2003. Dynamic expression of RGS4 in the developing nervous system and regulation by the neural type-specific transcription factor Phox2b. J. Neurosci. 23:10613–10621.
   PubMedGoogle Scholar
• Harrison, P. J., and D. R. Weinberger. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10:40–68.
   PubMed Web of Science ®Google Scholar
• Hatcher, J. P., D. N. Jones, D. C. Rogers, P. D. Hatcher, C. Reavill, J. J. Hagan, and A. J. Hunter. 2001. Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav. Brain Res. 125:43–47.
   PubMedGoogle Scholar
• Irwin, S. 1968. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13:222–257.
   PubMed Web of Science ®Google Scholar
• Jacob, J., M.-C. Tiveron, J.-F. Brunet, and S. Guthrie. 2000. Role of the target in the pathfinding of facial visceral motor axons. Mol. Cell. Neurosci. 16:14–26.
   PubMedGoogle Scholar
• Jiang, M., M. S. Gold, G. Boulay, K. Spicher, M. Peyton, P. Brabet, Y. Srinivasan, U. Rudolph, G. Ellison, and L. Birnbaumer. 1998. Multiple neurological abnormalities in mice deficient in the G protein Go. Proc. Natl. Acad. Sci. USA 95:3269–3274.
   PubMed Web of Science ®Google Scholar
• Kandel, E. R. 2000. Disorders of thought and volition: schizophrenia. In E. R. Kandel, J. H. Schwartz, and T. M. Jessell (ed.). Principles of neural science. McGraw-Hill, New York, N.Y.
   Google Scholar
• Kardestuncer, T., H. Wu, A. L. Lim, and E. J. Neer. 1998. Cardiac myocytes express mRNA for ten RGS proteins: changes in RGS mRNA expression in ventricular myocytes and cultured atria. FEBS Lett. 438:285–288.
   PubMed Web of Science ®Google Scholar
• Knittel, T., M. Kessel, M. H. Kim, and P. Gruss. 1995. A conserved enhancer of the human and murine Hoxa-7 gene specifies the anterior boundary of expression during embryonal development. Development 121:1077–1088.
   PubMedGoogle Scholar
• Lallemand, Y., V. Luria, R. Haffner-Krausz, and P. Lonai. 1998. Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res. 7:105–112.
   PubMed Web of Science ®Google Scholar
• Maldonado, R., A. Saiardi, O. Valverde, T. A. Samad, B. P. Roques, and E. Borrelli. 1997. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388:586–589.
   PubMed Web of Science ®Google Scholar
• Mirnics, K., F. A. Middleton, G. D. Stanwood, D. A. Lewis, and P. Levitt. 2001. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6:293–301.
   PubMed Web of Science ®Google Scholar
• Mittmann, C., C. H. Chung, G. Hoppner, C. Michalek, M. Nose, C. Schuler, A. Schuh, T. Eschenhagen, J. Weil, B. Pieske, S. Hirt, and T. Wieland. 2002. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc. Res. 55:778–786.
   PubMed Web of Science ®Google Scholar
• Morris, D. W., A. Rodgers, K. A. McGhee, S. Schwaiger, P. Scully, J. Quinn, D. Meagher, J. L. Waddington, M. Gill, and A. P. Corvin. 2004. Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. 125B:50–53.
   PubMedGoogle Scholar
• Nestler, E. J. 2004. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25:210–218.
   PubMed Web of Science ®Google Scholar
• Neubig, R. R., and D. P. Siderovski. 2002. Regulators of G-protein signalling as new central nervous system drug targets. Nat. Rev. Drug Discov. 1:187–197.
   PubMed Web of Science ®Google Scholar
• Nomoto, S., K. Adachi, L. X. Yang, Y. Hirata, S. Muraguchi, and K. Kiuchi. 1997. Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization. Biochem. Biophys. Res. Commun. 241:281–287.
   PubMedGoogle Scholar
• Offermanns, S., K. Hashimoto, M. Watanabe, W. Sun, H. Kurihara, R. F. Thompson, Y. Inoue, M. Kano, and M. I. Simon. 1997. Impaired motor coordination and persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking Galphaq. Proc. Natl. Acad. Sci. USA 94:14089–14094.
   PubMedGoogle Scholar
• Owen, V. J., P. B. Burton, A. J. Mullen, E. J. Birks, P. Barton, and M. H. Yacoub. 2001. Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. Eur. Heart J. 22:1015–1020.
   PubMedGoogle Scholar
• Pattyn, A., X. Morin, H. Cremer, C. Goridis, and J.-F. Brunet. 1997. Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development 124:4065–4075.
   PubMed Web of Science ®Google Scholar
• Potenza, M. N., S. J. Gold, A. Roby-Shemkowitz, M. R. Lerner, and E. J. Nestler. 1999. Effects of regulators of G protein-signaling proteins on the functional response of the mu-opioid receptor in a melanophore-based assay. J. Pharmacol. Exp. Ther. 291:482–491.
   PubMedGoogle Scholar
• Rahman, Z., S. J. Gold, M. N. Potenza, C. W. Cowan, Y. G. Ni, W. He, T. G. Wensel, and E. J. Nestler. 1999. Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J. Neurosci. 19:2016–2026.
   PubMedGoogle Scholar
• Rogers, J. H., P. Tamirisa, A. Kovacs, C. Weinheimer, M. Courtois, K. J. Blumer, D. P. Kelly, and A. J. Muslin. 1999. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J. Clin. Investig. 104:567–576.
   PubMed Web of Science ®Google Scholar
• Ross, E. M., and T. M. Wilkie. 2000. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69:795–827.
   PubMed Web of Science ®Google Scholar
• Tamirisa, P., K. J. Blumer, and A. J. Muslin. 1999. RGS4 inhibits G-protein signaling in cardiomyocytes. Circulation 99:441–447.
   PubMedGoogle Scholar
• Tang, M. K., G. R. Wang, P. Lu, R. H. Karas, M. Aronovitz, S. P. Heximer, K. M. Kaltenbronn, K. J. Blumer, D. P. Siderovski, Y. Zhu, and M. E. Mendelsohn. 2003. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9:1506–1512.
   PubMed Web of Science ®Google Scholar
• Thor, S., J. Ericson, T. Brännström, and T. Edlund. 1991. The homeodomain LIM protein Isl-1 is expressed in subsets of neurons and endocrine cells in the adult rat. Neuron 7:881–889.
   PubMedGoogle Scholar
• Tiveron, M.-C., M.-R. Hirsch, and J.-F. Brunet. 1996. The expression pattern of the transcription factor Phox2 delineates synaptic pathways of the autonomic nervous system. J. Neurosci. 16:7649–7660.
   PubMedGoogle Scholar
• Weiss, I. C., and J. Feldon. 2001. Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology 156:305–326.
   PubMed Web of Science ®Google Scholar
• Williams, J. T., M. J. Christie, and O. Manzoni. 2001. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 81:299–343.
   PubMed Web of Science ®Google Scholar
• Williams, N. M., A. Preece, G. Spurlock, N. Norton, H. J. Williams, R. G. McCreadie, P. Buckland, V. Sharkey, K. V. Chowdari, S. Zammit, V. Nimgaonkar, G. Kirov, M. J. Owen, and M. C. O'Donovan. 2004. Support for RGS4 as a susceptibility gene for schizophrenia. Biol. Psychiatry 55:192–195.
   PubMed Web of Science ®Google Scholar
• Wu, C., Q. Zeng, K. J. Blumer, and A. J. Muslin. 2000. RGS proteins inhibit Xwnt-8 signaling in Xenopus embryonic development. Development 127:2773–2784.
   PubMedGoogle Scholar
• Zachariou, V., D. Georgescu, N. Sanchez, Z. Rahman, R. DiLeone, O. Berton, R. L. Neve, L. J. Sim-Selley, D. E. Selley, S. J. Gold, and E. J. Nestler. 2003. Essential role for RGS9 in opiate action. Proc. Natl. Acad. Sci. USA 100:13656–13661.
   PubMed Web of Science ®Google Scholar
• Zeng, W., X. Xu, S. Popov, S. Mukhopadhyay, P. Chidiac, J. Swistok, W. Danho, K. A. Yagaloff, S. L. Fisher, E. M. Ross, S. Muallem, and T. M. Wilkie. 1998. The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. J. Biol. Chem. 273:34687–34690.
   PubMedGoogle Scholar
• Zhang, S., N. Watson, J. Zahner, J. N. Rottman, K. J. Blumer, and A. J. Muslin. 1998. RGS3 and RGS4 are GTPase activating proteins in the heart. J. Mol. Cell. Cardiol. 30:269–276.
   PubMedGoogle Scholar